[1]
“The Immunoreactivity of Uroplakin III in Urothelial Carcinoma of Urinary Bladder and Other Non- Urothelial Carcinoma”, MLU, vol. 19, no. 2, pp. 319–323, Aug. 2019, doi: 10.37506/mlu.v19i2.796.